Stephen Charles Anderson
Corporate Officer/Principal at University of British Columbia
Profile
Stephen Charles Anderson is a Professor at the University of British Columbia.
He previously worked as the Chief Financial Officer, Secretary & Controller at Westport Innovations, Inc. from 1998 to 2003, and as the Chief Financial Officer at Perceptronix Medical, Inc. in 2005.
He also served as the Chief Financial Officer at OncoGenex Technologies, Inc. and as the Chief Financial Officer & Secretary at OncoGenex Pharmaceuticals, Inc. from 2008 to 2010.
Anderson received his undergraduate and MBA degrees from the University of British Columbia.
Stephen Charles Anderson active positions
Companies | Position | Start |
---|---|---|
University of British Columbia | Corporate Officer/Principal | - |
Former positions of Stephen Charles Anderson
Companies | Position | End |
---|---|---|
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Director of Finance/CFO | 2010-02-23 |
OncoGenex Technologies, Inc.
OncoGenex Technologies, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Technologies, Inc. develops drugs for cancer patients. Its products are being developed to block the production of specific proteins associated with the development of treatment resistance which will increase survival time and improve the quality of life for cancer patients. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Director of Finance/CFO | 2008-08-21 |
Perceptronix Medical, Inc.
Perceptronix Medical, Inc. Medical/Nursing ServicesHealth Services Perceptronix Medical, Inc. provides cytology laboratory and cancer diagnostics services. It provides partnership opportunities for the distribution and test sales of quantitative cytology imaging machine including ClearCyte. The firm also provides software and staining kit Clear2C. Its products are used in hospitals, universities and commercial laboratories. The company was founded in 1999 and is headquartered in Vancouver, Canada. | Director of Finance/CFO | 2006-01-01 |
Westport Innovations, Inc.
Westport Innovations, Inc. Electrical ProductsProducer Manufacturing Westport Innovations Inc. provides low-emission engine and fuel system technologies utilizing gaseous fuels. It operates through the following business segments: Applied Technologies, On-Road Systems, Off-Road Systems, Corporate and Technology Investments, Cummins Westport (CWI), and Weichai Westport (WWI). The Applied Technologies segment engaged in designing, producing, and selling compressed natural gas (“CNG”) and liquefied petroleum gas (“LPG”) components and subsystems for natural gas vehicles of all types. The On-Road Systems segment engineers, designs, assembles and sells natural gas engine and vehicle systems for automotive, light commercial, and trucking. The Off-Road Systems segment engineering, designing, and marketing Westport proprietary natural gas technologies, including the Westport™ high pressure direct injection (“HPDI”) technology, Westport™ industrial engines and fuel systems for the off-road, large-engine applications such as mine trucks, locomotives, workboats, and petroleum exploration equipment. The Corporate and Technology Investments segment includes corporate costs such as research and development, general and administrative, marketing, interest and other charges, foreign exchange and depreciation that cannot be attributed to a particular segment and are incurred by all segments. The CWI segment serves the medium- to heavy-duty engine. The WWI segment develops, manufactures, and sells advanced, alternative fuel engines and parts that are widely used in city bus, coach, and heavy-duty truck applications in China or exported to other regions globally markets with spark ignited natural gas engines. The company was founded by David R. Demers on March 20, 1995 and is headquartered in Vancouver, Canada. | Director of Finance/CFO | 2003-01-01 |
Training of Stephen Charles Anderson
University of British Columbia | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
OncoGenex Technologies, Inc.
OncoGenex Technologies, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Technologies, Inc. develops drugs for cancer patients. Its products are being developed to block the production of specific proteins associated with the development of treatment resistance which will increase survival time and improve the quality of life for cancer patients. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Health Technology |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Health Technology |
Perceptronix Medical, Inc.
Perceptronix Medical, Inc. Medical/Nursing ServicesHealth Services Perceptronix Medical, Inc. provides cytology laboratory and cancer diagnostics services. It provides partnership opportunities for the distribution and test sales of quantitative cytology imaging machine including ClearCyte. The firm also provides software and staining kit Clear2C. Its products are used in hospitals, universities and commercial laboratories. The company was founded in 1999 and is headquartered in Vancouver, Canada. | Health Services |
Westport Innovations, Inc.
Westport Innovations, Inc. Electrical ProductsProducer Manufacturing Westport Innovations Inc. provides low-emission engine and fuel system technologies utilizing gaseous fuels. It operates through the following business segments: Applied Technologies, On-Road Systems, Off-Road Systems, Corporate and Technology Investments, Cummins Westport (CWI), and Weichai Westport (WWI). The Applied Technologies segment engaged in designing, producing, and selling compressed natural gas (“CNG”) and liquefied petroleum gas (“LPG”) components and subsystems for natural gas vehicles of all types. The On-Road Systems segment engineers, designs, assembles and sells natural gas engine and vehicle systems for automotive, light commercial, and trucking. The Off-Road Systems segment engineering, designing, and marketing Westport proprietary natural gas technologies, including the Westport™ high pressure direct injection (“HPDI”) technology, Westport™ industrial engines and fuel systems for the off-road, large-engine applications such as mine trucks, locomotives, workboats, and petroleum exploration equipment. The Corporate and Technology Investments segment includes corporate costs such as research and development, general and administrative, marketing, interest and other charges, foreign exchange and depreciation that cannot be attributed to a particular segment and are incurred by all segments. The CWI segment serves the medium- to heavy-duty engine. The WWI segment develops, manufactures, and sells advanced, alternative fuel engines and parts that are widely used in city bus, coach, and heavy-duty truck applications in China or exported to other regions globally markets with spark ignited natural gas engines. The company was founded by David R. Demers on March 20, 1995 and is headquartered in Vancouver, Canada. | Producer Manufacturing |
- Stock Market
- Insiders
- Stephen Charles Anderson